© 2021 MJH Life Sciences and Oncology Nursing News. All rights reserved.
© 2021 MJH Life Sciences™ and Oncology Nursing News. All rights reserved.
May 13, 2021
An intervention to decrease chemotherapy wait times led to better patient satisfaction and reduced anxiety.
May 07, 2021
When in-person classes on central venous catheter care were limited due to the COVID-19 pandemic, educational videos became even more important.
May 06, 2021
In honor of Nurses' Week, from May 6-12, we’re sharing what some patients, survivors, and caregivers had to say about how oncology nurses helped them along their cancer journey.
The FDA has granted a priority review to the supplemental new drug application for ivosidenib tablets as a treatment option for patients with previously treated, IDH1-mutant cholangiocarcinoma.
May 05, 2021
The FDA granted an accelerated approval to pembrolizumab plus trastuzumab, fluoropyrimidine- and platinum-containing chemotherapy for the frontline treatment of patients with locally advanced unresectable or metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma.
May 04, 2021
The rolling submission of a new drug application to the FDA for surufatinib for the treatment of patients with pancreatic and non-pancreatic neuroendocrine tumors has been completed.
May 02, 2021
The FDA has granted a priority review designation to a supplemental biologics license application for nivolumab for use as an adjuvant treatment in patients with surgically resected, high-risk, muscle-invasive urothelial carcinoma.
May 01, 2021
Each month, we take a look back at the most popular Oncology Nursing News® stories. Here are the top 5 stories from April 2021.
April 27, 2021
A recent study analyzed the benefits and work-related stressors of end-of-life care.
April 26, 2021
Breast cancer survivors may experience an increase in fear of recurrence after undergoing genomic testing that reveals risk.